Denali Therapeutics Inc. (DNLI)
NASDAQ · Healthcare
Denali Therapeutics Inc. Net Income 2016–2025
Denali Therapeutics Inc. annual/quarterly net income history and growth rate from 2016 to 2024. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Denali Therapeutics Inc. net income for the quarter ending September 30, 2024 was -107.2 M, a 7.89% increase year-over-year.
- Denali Therapeutics Inc. net income for the twelve months ending September 30, 2024 was -407.4 M, a 360.36% increase year-over-year.
- Denali Therapeutics Inc. annual net income for 2025 was -512.5 M, a 21.23% increase from 2024.
- Denali Therapeutics Inc. annual net income for 2024 was -422.8 M, a 191.12% increase from 2023.
- Denali Therapeutics Inc. annual net income for 2023 was -145.2 M, a 55.45% decrease from 2022.
- Denali Therapeutics Inc. annual net income for 2022 was -326.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Denali Therapeutics Inc. Net Income — FAQ
Denali Therapeutics Inc. (DNLI) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Denali Therapeutics Inc.'s net income?
Denali Therapeutics Inc. (DNLI) reported net income of -$513M for fiscal 2025.
Where can I see DNLI's net income history?
The chart and table above show Denali Therapeutics Inc.'s net income by year and by quarter, including the growth rate.